Technical Analysis for ESTA - Establishment Labs Holdings Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Flat |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Resistance | Bearish | -2.17% | |
| Multiple of Ten Bullish | Other | -2.17% | |
| Up 3 Days in a Row | Strength | -2.17% | |
| 50 DMA Support | Bullish | -1.00% | |
| Multiple of Ten Bullish | Other | -1.00% | |
| Outside Day | Range Expansion | -1.00% | |
| Gapped Down | Weakness | -1.00% | |
| NR7 | Range Contraction | 1.04% | |
| NR7-2 | Range Contraction | 1.04% | |
| 50 DMA Support | Bullish | 2.15% |
| Alert | Time |
|---|---|
| 10 DMA Support | 11 minutes ago |
| 60 Minute Opening Range Breakdown | 11 minutes ago |
| Down 3% | 11 minutes ago |
| Fell Below Previous Day's Low | 35 minutes ago |
| Down 2 % | 35 minutes ago |
Get this analysis on your stocks daily!
- Earnings date: 05/08/2024
Establishment Labs Holdings Inc. Description
Establishment Labs (ESTA) is a global medical technology company focused on improving patient safety and aesthetic outcomes, initially in the breast aesthetics and reconstruction market by designing, developing, manufacturing and marketing an innovative portfolio of silicone gel-filled breast implants, branded as Motiva Implants®, the centerpiece of the MotivaImagine® platform. Motiva Implants® are produced at two FDA compliant state-of-the-art facilities in Costa Rica and currently sold in over 60 countries through exclusive distributors or a direct salesforce. In March 2018, Establishment Labs received approval for an investigational device exemption (IDE) from the FDA to initiate the Motiva Implant® clinical trial in the United States. In addition to Motiva Implants®, Establishment Labs’ product and technologies portfolio includes Divina® 3D Simulation System, Puregraft, and MotivaImage® Centers.
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Clinical Medicine Medical Technology FDA Prosthetics Implant Silicone Aesthetics Patient Safety Biological Engineering Breast Surgery Simulation System Breast Implant Investigational Device Exemption
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 73.0 |
| 52 Week Low | 17.0 |
| Average Volume | 374,235 |
| 200-Day Moving Average | 42.80 |
| 50-Day Moving Average | 48.56 |
| 20-Day Moving Average | 51.09 |
| 10-Day Moving Average | 49.35 |
| Average True Range | 2.45 |
| RSI (14) | 53.05 |
| ADX | 22.41 |
| +DI | 19.02 |
| -DI | 27.96 |
| Chandelier Exit (Long, 3 ATRs) | 48.38 |
| Chandelier Exit (Short, 3 ATRs) | 52.21 |
| Upper Bollinger Bands | 55.55 |
| Lower Bollinger Band | 46.63 |
| Percent B (%b) | 0.45 |
| BandWidth | 17.46 |
| MACD Line | 0.09 |
| MACD Signal Line | 0.43 |
| MACD Histogram | -0.346 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 53.57 | ||||
| Resistance 3 (R3) | 53.51 | 52.48 | 53.07 | ||
| Resistance 2 (R2) | 52.48 | 51.72 | 52.50 | 52.91 | |
| Resistance 1 (R1) | 51.54 | 51.26 | 52.01 | 51.60 | 52.74 |
| Pivot Point | 50.51 | 50.51 | 50.74 | 50.53 | 50.51 |
| Support 1 (S1) | 49.57 | 49.75 | 50.04 | 49.63 | 48.48 |
| Support 2 (S2) | 48.54 | 49.29 | 48.56 | 48.31 | |
| Support 3 (S3) | 47.60 | 48.54 | 48.15 | ||
| Support 4 (S4) | 47.66 |
